一项具有里程碑意义的研究将一种新的中风装置与血液稀释剂作比较,有可能改变今后的治疗准则。 A landmark study compares a new stroke device to blood thinners, potentially changing future treatment guidelines.

Penumbra关于缺血中风治疗的一项新研究,比较了它针对传统血稀释剂的基于装置的方法,被贴上“标记”,可能会影响未来的医疗指导方针,尽管最终结果和监管审查尚未完成。 A new study by Penumbra on a treatment for ischemic stroke, comparing its device-based approach to traditional blood thinners, has been labeled "landmark" and may influence future medical guidelines, though final results and regulatory review are pending.